Lv41
730 积分 2023-07-20 加入
The pharmacological basis for nonpeptide agonism of the GLP-1 receptor by orforglipron
21天前
已完结
Orforglipron: A Novel Oral GLP-1 Agonist for the Treatment of Obesity and Diabetes
21天前
已完结
Global, regional, and national burden of chronic respiratory diseases and impact of the COVID-19 pandemic, 1990–2023: a Global Burden of Disease study
26天前
已完结
Global, regional, and national burden of diseases and injuries for adults 70 years and older: systematic analysis for the Global Burden of Disease 2019 Study
26天前
已完结
The prevalence of adherence to insulin therapy in patients with diabetes: A systematic review and meta-analysis
27天前
已完结
胰岛素注射技术误区解析及国际规范推荐
27天前
已完结
代谢性疾病的管理：关注机体异位脂肪沉积
29天前
已完结
Tirzepatide vs Insulin Lispro Added to Basal Insulin in Type 2 Diabetes
1个月前
已完结
Disease modifying therapies in diabetes and endocrinology
1个月前
已完结
2型糖尿病胰岛β细胞功能评估与保护临床专家共识
1个月前
已完结
皖公网安备34019202002308
